Drug-coated balloons for the prevention of vascular restenosis.

@article{Gray2010DrugcoatedBF,
  title={Drug-coated balloons for the prevention of vascular restenosis.},
  author={William A Gray and Juan F Granada},
  journal={Circulation},
  year={2010},
  volume={121 24},
  pages={2672-80}
}
From early in the history of percutaneous cardiovascular intervention, restenosis has been one of the most important clinical and biological measures of success, and a great deal of effort has been put into understanding the mechanisms responsible.1,2 Restenosis is the result of the interaction of a variety of mechanical and biological processes that begin immediately after balloon injury, including early vessel recoil,3,4 negative vascular remodeling,5 and excessive neointimal proliferation.5… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 45 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 54 references

Biological effect on coronary restenosis of bare metal stents crimped on paclitaxel coated balloons: preliminary animal data in the porcine overstretch model

  • T Thim, K Milewski, +6 authors JF. Granada
  • Am J Cardiol. 2009;104:177-D. Abstract
  • 2009

Inhibition of coronary neointimal hyperplasia in swine using a novel zotarolimus-eluting balloon catheter

  • B Cremers, JL Toner, +7 authors B. Scheller
  • Eur Heart J. 2009;30:532
  • 2009

Pilot study of paclitaxel eluting balloon (Cotavance Technology) followed by bare metal stent implantation: effect on neointimal formation in the iliofemoral arterial territory of normal swine

  • K Milewski, A Tellez, +7 authors GL. Kaluza
  • Am J Cardiol. 2009;104:181-D. Abstract
  • 2009

Similar Papers

Loading similar papers…